摘要
目的评价左西孟旦在射血分数降低充血性心力衰竭急性加重期的疗效及安全性。方法入选60例慢性充血性心力衰竭急性加重期的患者,随机分为对照组30例和治疗组30例。对照组以洋地黄类、ACEI/ARB、利尿剂、硝酸酯类等药物常规治疗,治疗组在对照组的治疗基础上加用左西孟旦,10 d后比较2组心功能分级、N末端B型利钠肽原(NT-pro BNP)血浆浓度、左室射血分数(LVEF)、舒张期末左室内径(LVDd)等指标。结果治疗10 d后2组心功能均有显著改善,血压、心率、LVDd下降、NT-pro BNP血浆浓度降低,LVEF升高,治疗前后差异均有统计学意义(P<0.05);与对照组相比,治疗组心率、NT-pro BNP血浆浓度、LVDd降低、LVEF升高更显著(P<0.05)。2组患者在治疗期间未发现有明显不良反应。结论短期应用左西孟旦治疗射血分数降低充血性心力衰竭急性加重期是安全有效的。
Objective To determine the short-term effect of levosimendan on patients with acute congestive heart failure with reduced ejection fraction. Methods A total of 60 patients who met the inclusion criteria were recruited and randomly divided into a group with levosimendan plus conventional therapy(group A), or a group with conventional therapy only(group B), 30 patients in each group. The concentration of NT-proBNP in the plasma, the clinical efficacy of treatment, the left ventricular ejection fraction(LVEF), and Left ventricular diastolic diameter(LVDd) were measured before and 10 days after the treatment. Results Statistically significant difference of plasma NT-proBNP concentration, LVDd, and LVEF were observed between before and after the treatment in both groups(P〈0.05). The plasma NT-proBNP concentration and LVDd in group A was decreased and LVEF in group A increased significantly compared with that of the group B(P〈0.05). Both significant effective rate and total effective rate of group A were higher than those of the group B(P〈0.05). Conclusion Levosimendan shows good short-term clinical effect in improving acute heart failure patients with reduced ejection fraction by reducing the plasma level of NT-proBNP and improving the left ventricular systolic function.
出处
《中南药学》
CAS
2015年第6期654-656,共3页
Central South Pharmacy
关键词
左西孟旦
射血分数降低
充血性心力衰竭
疗效
levosimendan
reduced ejection fraction
acute congestive heart failure
clinical effect